|
|
- IRMS - Nicolae Testemitanu SUMPh
- REVISTE MEDICALE NEINSTITUȚIONALE
- Arta Medica
- Arta Medica 2011
- Arta Medica Vol. 45 No.2, 2011 ediţie specială
Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12710/9286
| Title: | Tratamentul cu β-eritropoietina generică (Repretina®) şi calitatea vieţii pacienţilor dializaţi |
| Other Titles: | Generic β-erhythropoietine (Repretine®) therapy and the quality of life of the dialysed population |
| Authors: | Tănase, Adrian
Cepoida, Petru
Gaibu, Sergiu
Visterniceanu, Dorin
Evdochimov, Larisa
Postolache, Lilia
Cornea, Natalia |
| Issue Date: | 2011 |
| Publisher: | Asociaţia chirurgilor “Nicolae Anestiadi” din Republica Moldova |
| Citation: | TĂNASE, A., CEPOIDA, P., GAIBU, S., et al. Tratamentul cu β-eritropoietina generică (Repretina®) şi calitatea vieţii pacienţilor dializaţi. In: Arta Medica. 2011, nr. 2(45), pp. 266-268. ISSN 1810-1852. |
| Abstract: | Summary. The prospective 3-months study of the influence of β-erythropoietine (Repretine®) administration on the quality of life in 20 dialyzed patients is described. Treatment dose was 6,000 UI/week. After the treatment hemoglobin levels increased significantly and 70% patients reported the quality of life amelioration. As the physical component of the quality of life index increased from 33,81±1,56 points (M±m) till 38,51±1,49 points (p<0,05) and the psychological component decreased insignificantly from 45,71±6,97 points till 44,77±6,5 points (p>0,05), than composed health index increased due to the amelioration of the physical stage of the patients, that positively correlated with increased hemoglobin values. |
| URI: | https://repository.usmf.md/handle/20.500.12710/9286 |
| ISSN: | 1810-1852 |
| Appears in Collections: | Arta Medica Vol. 45 No.2, 2011 ediţie specială
|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
|
